Local immunosuppression in vascularized composite allotransplantation (VCA): A systematic review

Tasigiorgos, 2019, Five-year follow-up after face transplantation, N Engl J Med, 380, 2579, 10.1056/NEJMc1810468 Thuong, 2019, Vascularized composite allotransplantation - a Council of Europe position paper, Transpl Int, 32, 233, 10.1111/tri.13370 Ng, 2015, Memory T cells in vascularized composite allotransplantation, Vasc Compos Allotransplant, 2, 75, 10.1080/23723505.2016.1229649 Sosin, 2016, The face transplantation update: 2016, Plast Reconstr Surg, 137, 1841, 10.1097/PRS.0000000000002149 Mendenhall, 2018, Prevalence and distribution of potential vascularized composite allotransplant donors, implications for optimizing the donor-recipient match, Plast Reconstr Surg Global Open, 6, 214 Fisher, 2015, Micro and nanoparticle drug delivery systems for preventing allotransplant rejection, Clin Immunol, 160, 24, 10.1016/j.clim.2015.04.013 Fischer, 2014, Acute rejection in vascularized composite allotransplantation, Curr Opin Organ Transplant, 19, 531, 10.1097/MOT.0000000000000140 Kueckelhaus, 2016, Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration, Transpl Int, 29, 655, 10.1111/tri.12652 Kueckelhaus, 2015, Noninvasive monitoring of immune rejection in face transplant recipients, Plast Reconstr Surg, 136, 1082, 10.1097/PRS.0000000000001703 Hautz, 2013, Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study, Transpl Int, 26, 552, 10.1111/tri.12080 Gharb, 2013, Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation, Transplantation, 95, 1197, 10.1097/TP.0b013e31828bca61 Olariu, 2017, Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation, J Surg Res, 218, 49, 10.1016/j.jss.2017.05.046 Unadkat, 2017, Single implantable FK506 disk prevents rejection in vascularized composite allotransplantation, Plast Reconstr Surg, 139, 403e, 10.1097/PRS.0000000000002951 Gajanayake, 2014, A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft, Sci Transl Med, 6, 249, 10.1126/scitranslmed.3008778 Bahmani, 2018, Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival, J Clin Invest, 128, 4770, 10.1172/JCI120923 Dzhonova, 2018, Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation, Transplantation, 102, 1684, 10.1097/TP.0000000000002283 Schnider, 2013, Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential, Clin Dev Immunol, 2013, 10.1155/2013/495212 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, J Clin Epidemiol, 62, 1006, 10.1016/j.jclinepi.2009.06.005 Kilkenny, 2012, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, Osteoarthr Cartil, 20, 256, 10.1016/j.joca.2012.02.010 Kaufman, 2018, Keeping secrets: localized immunosuppression in VCA, Transplantation, 102, 1599, 10.1097/TP.0000000000002284 Shirbacheh, 1998, The case for local immunosuppression in composite tissue allotransplantation, Transplant Proc, 30, 2739, 10.1016/S0041-1345(98)00800-8 Gruber, 1994, Local immunosuppressive therapy in organ transplantation, Transplant Proc, 26, 3214 Colazo, 2019, Applied bioengineering in tissue reconstruction, replacement, and regeneration, Tissue Eng Part B: Reviews, 25, 259, 10.1089/ten.teb.2018.0325 Wood, 2012, Regulatory immune cells in transplantation, Nat Rev Immunol, 12, 417, 10.1038/nri3227 Hagemeyer, 2015, Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use, Nat Protoc, 10, 90, 10.1038/nprot.2014.177 Ma, 2019, Oral drug delivery systems for ulcerative colitis therapy: a comparative study with microparticles and nanoparticles, Curr Cancer Drug Targets, 19, 304, 10.2174/1568009618666181016152042 Rodriguez-Velazquez, 2015, Polysaccharide-based nanobiomaterials as controlled release systems for tissue engineering applications, Curr Pharm Des, 21, 4837, 10.2174/1381612821666150820101029 Saari, 2015, Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells, J Control Release, 220, 727, 10.1016/j.jconrel.2015.09.031 Savelyeva, 2017, Vaterite coatings on electrospun polymeric fibers for biomedical applications, J Biomed Mater Res A, 105, 94, 10.1002/jbm.a.35870 Fries, 2019, Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: a proof of concept study, PLoS ONE, 14, 10.1371/journal.pone.0210914 Sutter, 2019, Delivery of rapamycin using in situ forming implants promotes immunoregulation and vascularized composite allograft survival, Sci Rep, 9, 9269, 10.1038/s41598-019-45759-y Hautz, 2010, Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation, Am J Transplant, 10, 1200, 10.1111/j.1600-6143.2010.03075.x Azzi, 2016, Targeted delivery of immunomodulators to lymph nodes, Cell Rep, 15, 1202, 10.1016/j.celrep.2016.04.007 Chaudhry, 2015, Defining the role of skin and mucosal biopsy in facial allotransplantation: a 2-year review and analysis of histology, Plast Reconstr Surg, 136, 559, 10.1097/PRS.0000000000001529 Blueschke, 2018, Enhanced drug delivery to the skin using liposomes, Plast Reconstr Surg Glob Open, 6, e1739, 10.1097/GOX.0000000000001739 Sinha, 2013, Split rejection in vascularized composite allotransplantation, Eplasty, 13, e53 Kauke, 2020, Mucosa and rejection in facial vascularized composite allotransplantation: a systematic review, Transplantation, 10.1097/TP.0000000000003171